Sven De Bock

Sven De Bock is a researcher at the Institute of Tropical Medicine Antwerp (ITM), Belgium, specializing in mycobacteriology with a focus on tuberculosis diagnostics in resource-limited settings. His work centers on developing and evaluating novel diagnostic methodologies for tuberculosis, particularly in Guinea.

His research interests span tuberculosis diagnostics, mycobacteriology, and global health. De Bock has pioneered investigations into alternative sampling techniques like face mask sampling (FMS) and rapid culture-based drug susceptibility testing. His Guinea-based studies critically assess the efficacy of non-traditional diagnostic approaches against conventional sputum methods, addressing critical gaps in tuberculosis detection infrastructure.

Recent publications reveal a consistent trajectory toward accelerating tuberculosis diagnostic capabilities. The 2025 study introduced a BSL2-compatible bedaquiline susceptibility testing protocol yielding results in 15 days, while the 2023 Guinea trial quantified FMS's reduced sensitivity versus sputum. Both works emphasize practical, field-deployable solutions for endemic regions.

De Bock operates within ITM's Mycobacteriology unit, collaborating extensively with Guinean institutions and international partners like the University of Antwerp. His fingerprint analysis confirms overwhelming focus on Guinea-related medical research (100%) with significant microscopy applications (9%).